Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PECS Block for Persistent Postoperative Pain in Breast Surgery
NCT03084536Phase 2
Key facts
- Status
- Completed
- Start
- Jun 2017
- Primary completion
- Feb 2021
- Countries
- 1
- Sponsor
- Washington University School of Medicine
- Modality
- Small Molecules
- Drugs
- bupivacaine
- Conditions
- chronic post-surgical pain (CPSP)
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine in chronic post-surgical pain (CPSP), sponsored by Washington University School of Medicine. Started Jun 2017; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Adult women scheduled for elective breast cancer surgery involving the axilla (e.g., axillary dissection, mastectomy with reconstruction), enrolled in the SATISFY-SOS study, with no prior major surgery on the target breast/axilla and no pre-existing axillary pain.
04
Registry description
In this double blinded randomized placebo-controlled trial, 160 subjects scheduled for breast surgery involving the axilla will be administered a multimodal pain regimen including acetaminophen, dexamethasone, celecoxib, and gabapentin. 80 subjects will also receive a Pectoral Nerve blocks I and II (PECS I and II block) preoperatively.
Beyond the preview
Go deeper on NCT03084536.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03084536.